
CAN win BNMS Preclinical Prize for Poster Abstract Presentation
We are pleased to share that we have won the preclinical prize for our abstract and poster presentation at British Nuclear Medicine Society (BNMS) Spring Meeting in Glasgow this year! 🏆
The award is given to company’s who’s presentations and posters focus on all aspects of research that is before clinical involvement, or biological studies that help understand clinical studies. This can include:
· New radiochemistry – without a GMP component (whereas improvements or GMP of existing radiochemistry is more like radiopharmacy)
· In vitro mechanistic biology of new/existing tracers or therapeutics
· In vivo animal imaging of new tracers or existing tracers or therapeutics where mechanistic understanding is enhanced
· Physics/radiobiology in preclinical imaging/therapy
It is fantastic that the BNMS and the industry recognise our contribution to the field and we hope to continue to be impactful as our Nuclear Medicine portfolio continues to grow.
At the Spring Meeting, our Scientific Officer, Amin Choudhury presented our development of our state of the art Hot Cell design, as part of the Medical Radionuclide Innovation Programme (MRIP), for the manufacturing of theranostics, namely Pb212 in the UK hospital environment. This had a high element of innovation and the journey taught our business an incredible amount. CAN were proud to present this topic and we are delighted that the BNMS recognised our commitment as well.
A special shout out to Paul Adlem, Dave Barker and Sam Rickson on their contribution.
Read more about what we do in Nuclear Medicine here: Nuclear Medicines – Cyclife Aquila Nuclear | EDF Group